Overview
Cardiomyopathy is a group of diseases of the heart muscle in which the myocardium becomes structurally and functionally abnormal, impairing the heart's ability to fill or pump effectively. The principal phenotypes are dilated, hypertrophic, restrictive, and arrhythmogenic forms, with causes spanning genetic mutation, infection, toxic and metabolic insults, infiltrative processes, and autoimmune disease. Presentation ranges from arrhythmia and heart failure to sudden cardiac death, and accurate characterisation through clinical, electrocardiographic, and echocardiographic assessment guides management. The studies collected here illustrate this diversity. Hypertrophic and non-compaction phenotypes are described in case reports, including apical hypertrophic cardiomyopathy with coronary fistulas and left ventricular non-compaction associated with a developmental syndrome and pre-excitation. Acquired myocardial injury features in work on rapid myocardial calcification following severe sepsis. The broader heart-failure context appears in studies of heart failure in family practice and of cardiorenal signalling pathways. Preclinical and mechanistic dimensions are represented by in vitro models of cardiac function and cardiotoxicity testing using cardiomyocyte cell lines. Comparative cardiac assessment in coronary disease and reduced physical activity in patients with thalassaemia extend the clinical picture. Together this literature frames cardiomyopathy as a mechanistically heterogeneous disorder of heart muscle in which precise diagnosis and an understanding of underlying cause shape prognosis and treatment.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Sotos Syndrome, Isolated Left Ventricular Non Compaction Cardiomyopathy and Ventricular Pre Excitation: A Case Report.
Rapid Calcification of Myocardium as Sequela from Severe Sepsis
Heart Failure in Family Medicine
In vitro Assessment of the Biofield Treated Test Item on Cardiac Function Using Rat Cardiomyocytes Cell Line (H9c2) via Multiparametric Analysis
In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
A Role for in Vitro Disease Models in the Landscape of Preclinical Cardiotoxicity and Safety Testing
Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
Cardiorenal Signaling Pathways in Heart Failure: Good and Bad News
A Clinical, Electrocardiographic and Echocardiographic Comparison of Patients with Single Vs Multivessel Disease Presenting with Acute Coronary Syndromes
Reduced Physical Activity Patterns in Patients with Thalassemia Compared to Healthy Controls
How this research is being cited
The 12 articles above have been cited 48 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · PLOS One
-
2026 · Immunity, Inflammation and Disease
-
2025 · Cureus
-
2025 · Cureus
-
2024 · British Journal of Haematology
-
2024 · British Journal of Haematology
-
V. De Sanctis et al. · 2023 · Acta bio-medica : Atenei Parmensis
-
2022 · Open Journal of Urology
A sample of recent works citing this journal's research on Cardiomyopathy, linking to each citing work.